English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/141508
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy

AuthorsJaffrès, Paul-Alain; Gajate, Consuelo; Bouchet, Ana Maria; Couthon-Gourvès, Hélène; Chantôme, Aurélie; Potier-Cartereau, Marie; Besson, Pierre; Bougnoux, Philippe; Mollinedo, Faustino ; Vandier, Christophe
KeywordsAlkyl ether lipids
Lipid rafts
Ion channel
Death receptor
Apoptosis
Cell migration
Issue DateSep-2016
PublisherElsevier
CitationPharmacology & Therapeutics 165:114–131 (2016)
AbstractSynthetic alkyl lipids, such as the ether lipids edelfosine (1-O-octadecyl-2-O-methyl-rac- glycero-3-phosphocholine) and ohmline (1-O-hexadecyl-2-O-methyl-rac-glycero-3-β- lactose), are forming a class of antitumor agents that target cell membranes to induce apoptosis and to decrease cell migration/invasion, leading to the inhibition of tumor and metastasis development. In this review, we present the structure-activity relationship of edelfosine and ohmline, and we point out differences and similarities between these two amphiphilic compounds. We also discuss the mechanisms of action of these synthetic alkyl ether lipids (involving, among other structures and molecules, membrane domains, Fas/CD95 death receptor signaling, and ion channels), and highlight a key role for lipid rafts in the underlying process. The reorganization of lipid raft membrane domains induced by these alkyl lipids affects the function of death receptors and ion channels, thus leading to apoptosis and inhibition of cancer cell migration. The possible therapeutic use of these alkyl lipids and the clinical perspectives for these lipids in prevention or/and treatment of tumor development and metastasis are also discussed.
Description64 p.-6 fig.
Publisher version (URL)http://dx.doi.org/10.1016/j.pharmthera.2016.06.003
URIhttp://hdl.handle.net/10261/141508
DOI10.1016/j.pharmthera.2016.06.003
ISSN0163-7258
E-ISSN1879-016X
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
Jaffres_AlkylEtherLipids_Manuscript & fig..docPostprint1,63 MBMicrosoft WordView/Open
Show full item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.